Non-invasive sublingual conscious sedation compounded formulations*

iv bag
Patented non-invasive, non-opioid sublingual compounded formulation is now available without the need of individual prescriptions.

The MKO Melt® includes Midazolam, Ketamine HCl, and Ondansetron* and is administered under the tongue. Click here for details on the MKO compounded formulation.

  • Midazolam 3mg (Sedative)
  • Ketamine HCl 25mg (Anesthetic)
  • Ondansetron 2mg (Antiemetic)

The MKO Melt compounded formulation was developed by physicians and pharmacists as an option for appropriate patients.

MKO Melt

Midazolam, Ketamine HCl, and Ondansetron

IV Free Administration

The MeltTM can be administered under the tongue within minutes and typically dissolves within 2-5 minutes.

503B Outsourcing Facility

It is available from Imprimis’ FDA Registered 503B Outsourcing Facility and can be purchased for $15 per troche without the need of individual prescriptions. FDA Outsourcing Facilities are required to follow cGMP guidelines to safeguard the quality and safety of every compounded medication dispensed. Visit www.imprimisrx.com/order503b/ to order today!

“It is one of the best things we have done for the patient experience, not to mention the surgeon and nurses experience.”

Dr. John Berdahl, Board Certified Ophthalmologist

*For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request.